MAM
WGS icon

Morse Asset Management’s GeneDx Holdings WGS Stock Holding History

Morse Asset Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Sell
200
-25,019
-99% -$2.28M ﹤0.01% 285
2025
Q4 		$3.28M Sell
25,219
-2,226
-8% -$306K 0.66% 47
2025
Q3 		$2.96M Buy
27,445
+60
+0.2% +$6.54K 0.59% 49
2025
Q2 		$2.53M Buy
27,385
+6,974
+34% +$547K 0.55% 48
2025
Q1 		$1.81M Buy
+20,411
New +$1.77M 0.46% 55

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morse Asset Management's WGS Position: Q1 2026 in Review

Morse Asset Management reduced its GeneDx Holdings (WGS) stake by 99% in Q1 2026, selling an estimated $2.28M and leaving 200 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

Morse Asset Management first reported a position in WGS in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.28M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Morse Asset Management held 200 shares of GeneDx Holdings worth $12.8K as of Q1 2026.
  • Morse Asset Management sold 25,019 GeneDx Holdings shares in Q1 2026, an estimated $2.28M.
  • GeneDx Holdings made up ﹤0.01% of Morse Asset Management's portfolio in Q1 2026, its #285 holding.
  • Morse Asset Management first reported a position in GeneDx Holdings in Q1 2025 and has held it in 5 quarters since.
  • Morse Asset Management's GeneDx Holdings position peaked at $3.28M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Morse Asset Management's 13F filing for Q1 2026, filed 14 May 2026.